SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 254 filers reported holding SAGE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $12,444,000 | -32.0% | 88,700 | -11.3% | 0.76% | -28.0% |
| Q2 2019 | $18,309,000 | -11.5% | 100,000 | -23.1% | 1.05% | -24.7% |
| Q1 2019 | $20,677,000 | -41.3% | 130,000 | -64.6% | 1.40% | -51.1% |
| Q4 2018 | $35,226,000 | +31.3% | 367,732 | +93.5% | 2.86% | +64.0% |
| Q3 2018 | $26,838,000 | -28.4% | 190,000 | -20.7% | 1.74% | -37.2% |
| Q2 2018 | $37,508,000 | -2.8% | 239,619 | 0.0% | 2.78% | -3.5% |
| Q1 2018 | $38,595,000 | +75.5% | 239,619 | -67.2% | 2.88% | -7.8% |
| Q2 2016 | $21,995,000 | -27.4% | 730,000 | -22.8% | 3.12% | -31.7% |
| Q1 2016 | $30,297,000 | +65.0% | 945,000 | +200.0% | 4.56% | +107.7% |
| Q4 2015 | $18,365,000 | +80.8% | 315,000 | +31.2% | 2.20% | +35.5% |
| Q3 2015 | $10,157,000 | +23520.9% | 240,000 | +28135.3% | 1.62% | +23071.4% |
| Q1 2015 | $43,000 | +16.2% | 850 | -15.0% | 0.01% | +16.7% |
| Q4 2014 | $37,000 | -88.3% | 1,000 | -90.0% | 0.01% | -90.8% |
| Q3 2014 | $315,000 | – | 10,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Rock Ventures, LLC | 9,773,073 | $490,901,000 | 52.36% |
| Ghost Tree Capital, LLC | 240,000 | $12,056,000 | 2.17% |
| EcoR1 Capital, LLC | 112,455 | $5,649,000 | 1.88% |
| New Leaf Venture Partners, L.L.C. | 43,770 | $2,199,000 | 1.49% |
| AlpInvest Partners B.V. | 12,195 | $613,000 | 1.15% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 595,443 | $29,909,000 | 0.97% |
| APEX CAPITAL, LLC | 190,000 | $9,544,000 | 0.69% |
| OAK RIDGE INVESTMENTS LLC | 385,770 | $19,377,000 | 0.43% |
| Lombard Odier Asset Management (USA) Corp | 92,089 | $4,626,000 | 0.37% |
| SPHERA FUNDS MANAGEMENT LTD. | 65,724 | $3,301,000 | 0.34% |